Atarax (PSYCHOANALEPTICS)

Quick links

Choose a section

Quick links to important sections

Advertisements

Atarax (PSYCHOANALEPTICS)

Selected form

Advertisements
Advertisements

Overview of Atarax (PSYCHOANALEPTICS)

Property Description
Active ingredient Hydroxyzine dihydrochloride
Form Oral tablets, Oral syrup, Injection solution
Pharmacological class First-generation antihistamine, Anxiolytic
Common use Relief of pruritus, Management of nervousness
Origin Synthetic compound (Piperazine derivative)

What Type of Medicine is Atarax (Hydroxyzine)?

Atarax is a prescription-only medication whose active component is Hydroxyzine dihydrochloride, a synthetic compound chemically characterized as a piperazine derivative. It is classified as a first-generation antihistamine, a designation supported by pharmacological studies, but is also recognized for its distinct anxiolytic and sedative properties. The compound is notably distinct within its class because it is clinically recognized for its potent central effects, setting it apart from non-sedating, second-generation antihistamines.

Composition, Origin, and Available Forms

The synthetic compound, Hydroxyzine, is formulated as a single-ingredient drug for systemic delivery. The medication is physically prepared in multiple dosage forms, including oral options like tablets and a liquid syrup, as well as a sterile solution for intramuscular injection. The availability of an injectable format is a differentiating factor, making it particularly suitable for use in supervised settings requiring rapid intervention.

General Therapeutic Purpose and Foundational Action

The general therapeutic purpose of the medication is to provide relief from persistent pruritus (itching) and to manage generalized states of anxiety or nervous agitation, for which it has been widely utilized for decades. This benefit is rooted in its mechanism as a potent histamine H1-receptor antagonist, which counteracts the allergic response, and its ability to produce a central calming or sedative effect.

Advertisements

What side effects are possible with Atarax (PSYCHOANALEPTICS)?

Possible Side Effects and Safety Information

The official safety profile of Hydroxyzine, as described in governmental regulatory documents, classifies adverse effects primarily by frequency and the physiological system affected.

Frequency Classification of Adverse Reactions

The most commonly classified effects relate to the Central Nervous System (CNS) and anticholinergic actions. Sedation or somnolence is listed as a very common adverse reaction. Common effects include dry mouth, headache, and fatigue. Less frequently documented effects (uncommon to rare) can involve dizziness, tremor, confusion, agitation, and, rarely, tachycardia, hallucinations, or convulsions.

Key System-Organ Classes and Serious Safety Concerns

Adverse reactions are grouped into System-Organ Classes (SOCs), with effects noted in the Nervous System, Gastrointestinal, Skin, and Psychiatric domains. However, the regulatory documents give particular emphasis to serious risks within the Cardiac Disorders SOC. The official label explicitly documents the risk of QT interval prolongation and the potential for the severe ventricular arrhythmia Torsade de Pointes.

Additionally, rare but serious reactions have been documented, including severe cutaneous reactions (such as Stevens-Johnson syndrome) and systemic hypersensitivity events like anaphylactic shock.

Population-Specific Safety Statements

Official safety information details constraints for specific patient groups. A lower starting dose is generally required for older adults due to an increased risk of sedation and anticholinergic effects. Dose reduction is also mandated for individuals with renal or hepatic impairment. The use of the medicine is officially contraindicated during pregnancy and breastfeeding.


Safety-Related Restrictions

Use is absolutely contraindicated in individuals with pre-existing known acquired or congenital QT interval prolongation or other significant cardiac risk factors, as explicitly stated in the prescribing information.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Immediately seek medical help for any suspected overdose of Atarax. A specific antidote is not available, and management is supportive. The most commonly reported sign of overdose is hypersedation, but more serious clinical events may occur.

Overdose can affect several major body systems, including the central nervous system and the cardiovascular system. Official documentation states that overdose may cause QT prolongation and Torsade de Pointes, a type of serious cardiac rhythm abnormality. Due to this risk, ECG monitoring is recommended in all cases of suspected overdose.

Primary Overdose Manifestations Emergency Response as Documented
Central Nervous System: Hypersedation, stupor, convulsions. Induce vomiting or perform gastric lavage.
Gastrointestinal: Nausea and vomiting. Provide general supportive care.
Cardiovascular: QT prolongation, Torsade de Pointes. Monitor vital signs and ECG closely.

Hypotension may be managed with intravenous fluids and vasopressors, though regulatory information specifically advises not to use epinephrine as it counteracts its pressor action. Because hydroxyzine is highly distributed and has high plasma protein binding, it is considered doubtful that hemodialysis would be of any value. However, the possibility of co-ingestion of other agents, such as barbiturates, should be borne in mind.

Advertisements

Therapeutic Uses of Atarax (PSYCHOANALEPTICS)

What Atarax (Hydroxyzine) Treats: Main Uses and Benefits

The primary therapeutic role of Atarax (Hydroxyzine) involves providing symptomatic relief across key domains involving heightened physiological and emotional distress. Hydroxyzine is indicated for the relief of anxiety, tension, and allergic pruritus. It is commonly used when short-term symptomatic assistance is needed.

Relief from Persistent Allergic Itching

This domain is applied across domains where additional symptomatic support is needed to manage intense, widespread pruritus (itching) that stems from allergic conditions. It is relevant in conditions presenting with systemic or localized discomfort, such as chronic urticaria and atopic dermatoses. The medication provides support that helps ease the overall symptom burden, which contributes to improved day-to-day comfort and may assist with maintaining functional stability by reducing sleep-disrupting symptoms.

Management of Nervous Tension and Acute Anxiety

The medication is relevant in contexts marked by increased discomfort or tension, specifically for the symptomatic relief of generalized nervousness and emotional tension. It helps address symptom clusters that may become intense or disruptive. The medication may assist with a supportive calming effect, which contributes to maintaining a sense of stability when symptoms are more noticeable and helps patients cope more steadily with symptom fluctuations during periods of increased distress.

Supportive Sedation in Clinical Scenarios

Hydroxyzine is also applied in clinical settings that involve acute or unstable symptom patterns, such as its use as a premedication before general anesthesia or certain medical procedures. It is relevant when symptoms become temporarily overwhelming due to situational stress. This application is relevant for easing symptomatic discomfort related to situational stress and helps improve day-to-day comfort during symptomatic periods.


Quick Fact: Support for Persistent Itching and Tension

Regulatory References

  1. FDA Drug Label via DailyMed, Hydroxyzine is indicated for the relief of anxiety, tension, and allergic pruritus
Advertisements

Eligibility and Restrictions for Use

Contraindicated Populations

Eligibility for the use of hydroxyzine is strictly defined by regulatory guidelines. The medicine is absolutely contraindicated and must not be used by patients with a known or acquired prolonged QT interval due to the risk of serious cardiac arrhythmia. Use is also prohibited in patients with a known hypersensitivity to hydroxyzine, its metabolite cetirizine, or related compounds. Regulatory labeling further prohibits use in women in early pregnancy and in nursing mothers (lactation).


Restricted and Conditional Use

For several populations, eligibility is conditional. Patients who are elderly (geriatric) or who have moderate or severe renal impairment or hepatic dysfunction require a mandatory dose reduction as specified in prescribing information. Use also requires caution in patients with specific comorbid conditions that are sensitive to anticholinergic effects, such as narrow-angle glaucoma, bladder outflow obstruction, and pre-existing electrolyte imbalances. Use is established for the adult population and for the pediatric population over specific age thresholds for labeled indications.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Risk of Serious Cardiac Effects

Atarax (hydroxyzine) is associated with a risk of QT interval prolongation and an abnormal heart rhythm called Torsade de Pointes. Due to this risk, the co-administration of hydroxyzine is strictly contraindicated with other medicines known to prolong the QT/QTc interval. This includes specific antiarrhythmics, antipsychotics, antidepressants, and certain antibiotics and antifungals. Concomitant use with potent inhibitors of the CYP3A4/5 liver enzyme, which can increase the concentration of hydroxyzine in the blood, is also contraindicated.

CNS Depressants and Potentiation

Hydroxyzine's effects are potentiated by, and additively increase the effects of, other Central Nervous System (CNS) depressants. This includes narcotics, non-narcotic analgesics, barbiturates, hypnotics, sedatives, and alcohol. If combination with these agents is necessary, the dosage of the CNS depressant should be reduced and adjusted individually. Caution is also advised with medicines that cause electrolyte depletion (e.g., hypokalemia), as this may increase the risk of heart rhythm abnormalities.

Advertisements

Mechanism of Action

How Hydroxyzine Works

Hydroxyzine, a psychoanaleptic, functions as a receptor antagonist, modulating specific neurotransmitter and mediator systems across both the central and peripheral nervous systems. Its pharmacodynamic profile involves binding to multiple molecular targets.


H1 Receptor Antagonism

Its primary mechanistic domain is functioning as an inverse agonist at the histamine H1 receptor. This action blocks the ability of endogenous histamine to activate these receptors, thereby suppressing the H1-mediated signaling cascade. The physiological consequence is a decrease in histamine-driven signaling, leading to a shift toward a less active signaling state in targeted tissues.


Central Pathway Modulation

The drug also affects central nervous system pathways through an antagonistic effect on the serotonin 5-HT2A receptor and, to a lesser extent, on the dopamine D2 receptor. This pathway modulation alters neurotransmission, resulting in changes to the overall CNS physiological state.


Muscarinic Receptor Engagement

A third domain involves the antagonism of muscarinic acetylcholine receptors. This engagement produces anticholinergic effects, leading to a decrease in the contraction of smooth muscle and secretions, which modifies the functional state within affected peripheral systems.

Advertisements

Dosage and Administration Information

The administration of hydroxyzine is standardized through approved routes and specific dosage protocols outlined in regulatory documents. The medication is officially available for oral intake as tablets, capsules, or syrup, and as a sterile solution intended for deep intramuscular (IM) injection.

The general principle of use mandates that the medicine be administered at the lowest effective dose and for the shortest possible duration. For adults, the dosing frequency is typically a divided daily dose, often 3 to 4 times a day. For instance, the regimen for pruritus management is 25 mg per dose, while doses for anxiety relief may range from 50 to 100 mg per administration.

Official Administration Constraints

The injectable solution is reserved only for IM use, and its administration is prohibited via subcutaneous, intravenous, or intra-arterial routes. For special populations, such as older adults, official guidance specifies that the dose must be cautious, often limiting the maximum total daily dose to 50 mg in many regions. The efficacy for continuous use beyond 4 months for anxiety management has not been established in systematic studies.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research has explored the drug's effect on specific inflammatory pathways. Studies examined the drug's effect both as a monotherapy and when compared to an existing standard-of-care treatment.


Phase II Trials: Combination vs. Monotherapy

The primary research goal was to examine whether the combination therapy shows differences in outcomes compared to monotherapy. These trials focused on identifying dosing parameters that were then evaluated, alongside the initial tolerability profile.

  • Study 1: Efficacy Endpoints Study 1 examined whether combination therapy affected inflammatory biomarkers in 300 participants over six months. Study 1 reported that a median decrease in the primary biomarker and a decrease in disease markers were observed over the study period.

  • Study 2: Symptom Changes Study 2 investigated whether the drug affected the time to symptom score change in a cohort of participants experiencing acute flare-ups. The study focused on the average time until participants reported a specific level of symptom score change. The study protocol specified the dose and duration of the drug received by participants.


Phase III Trials: Long-Term Follow-up and Specific Populations

Research compared the combination to monotherapy in a larger, multicenter trial (N=1,200) with a longer follow-up period (12 months). This trial was designed to gather more extensive data on long-term changes and the incidence of reported side effects.

  • Special Population Data Phase III results showed that the new formulation was evaluated in participants over 65, focusing on standard safety and tolerability measures. Data also suggests that the drug was studied in participants with milder forms of the condition.

  • Adherence and Protocol The study’s protocol required participants to complete the full course of therapy to be included in the final analysis of efficacy measures. Phase III trial results provided further data on reported adverse events across the cohort. The study evaluated the tolerability profile in a subgroup of participants with specific pre-existing conditions who were enrolled in the trial.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Atarax (PSYCHOANALEPTICS) (FAQ)

Q: What is the main reason a doctor would prescribe Atarax?

A: Official product labeling describes Atarax (hydroxyzine) uses including the management of anxiety and tension, the management of pruritus (itching) due to allergic conditions, and use as a sedative before and after general anesthesia. A healthcare provider utilizes these approved indications when deciding whether to prescribe the medication.

Q: Is Atarax considered a narcotic or controlled substance?

A: Regulatory classification indicates that hydroxyzine is not a narcotic, and it is not classified as a controlled substance under the U.S. Controlled Substances Act. This means it does not fall under the same federal scheduling rules as certain other sedatives or pain medications.

Q: What is the difference between Atarax and Benadryl (diphenhydramine)?

A: Both Atarax (hydroxyzine) and diphenhydramine are classified in official documents as first-generation H1 antihistamines, and they share properties like causing sedation. Although they belong to different chemical subclasses, official documents focus on the approved uses of each drug rather than providing direct comparisons.

Q: Does Atarax make you sleepy right away?

A: Drowsiness or sedation is a common, documented side effect of Atarax. Regulatory documents state that this effect may occur. Because of this possibility, patients are cautioned against activities requiring full mental alertness until they know how the drug affects them.

Q: How long does the drowsy effect of Atarax usually last?

A: Official information indicates that the sedative effects, such as drowsiness, are often documented as being transitory and may lessen after a few days of consistent use. The average elimination half-life of the medication in adults is documented to be approximately 20 hours.

Q: Is Atarax used for anxiety only, or does it have other uses?

A: Official product indications show that in addition to anxiety and tension management, Atarax is approved for the treatment of itching (pruritus) due to allergic conditions, and for use as a sedative before and after surgery.

Q: Can Atarax be used long-term?

A: Regulatory documents state that the effectiveness of hydroxyzine as an antianxiety agent has not been assessed by systematic clinical studies for use longer than four months. General regulatory guidance recommends that the medicine be administered for the shortest possible duration.

Q: Is Atarax safe to take with common pain relievers like Tylenol (acetaminophen)?

A: Official drug interaction information focuses on the risk of increased effects when combined with Central Nervous System (CNS) depressants. Acetaminophen is typically not listed as a significant interaction for increased sedation, but any combination of medications should be reviewed with a healthcare provider.

Q: What are the most common side effects of Atarax mentioned by patients?

A: The most frequently documented undesirable effects in official regulatory reports include drowsiness, dry mouth, and occasional involuntary motor activity (such as tremor or convulsions). The latter effects are most often reported at doses higher than those generally recommended.

Q: Do you always feel extremely drowsy when taking Atarax?

A: Official labeling notes that drowsiness is documented as being transitory and may lessen within a few days of consistent therapy or upon dosage reduction. Because of the possibility of drowsiness, patients are cautioned against engaging in activities requiring complete mental alertness until the drug's effect is known.

Q: Can Atarax affect your ability to drive or operate machinery?

A: Yes, official warnings state that patients should be cautioned against driving a car or operating dangerous machinery while taking the medication. This is due to the potential for drowsiness to occur.

Q: Is it true that Atarax is also used for itching or allergies?

A: Yes, official indications list its use in managing pruritus (itching) that is due to allergic conditions. This includes conditions like chronic urticaria, atopic, and contact dermatoses.

Q: What kind of studies have been done on Atarax for anxiety relief?

A: Official documents describe clinical studies that supported the drug's effectiveness in managing anxiety and tension associated with psychoneurosis. The documents also note that the results of long-term use (more than four months) have not been systematically assessed.

Q: Is Atarax safe for older adults to use?

A: Official guidance often recommends caution when the medication is used by older adults. Dose selection for this population reflects the need for lower doses, considering that older adults may have increased susceptibility to side effects like over-sedation or confusion.

Q: Why is Atarax sometimes called a 'mild' tranquilizer?

A: Hydroxyzine is a first-generation antihistamine that is officially documented to exhibit both anxiolytic (anxiety-reducing) and sedative properties. It is thought to exert these effects by decreasing activity in certain subcortical regions of the Central Nervous System.

Q: Can Atarax interact with herbal supplements like St. John's Wort?

A: Official documents caution against combining hydroxyzine with other Central Nervous System (CNS) depressants. If an herbal supplement has known CNS effects, such as St. John's Wort, there is a potential for enhanced side effects like dizziness and drowsiness.

Q: What are the signs of a serious or rare side effect from Atarax?

A: Serious side effects documented in official warnings include rare cases of heart rhythm changes like QT prolongation, which can lead to symptoms such as dizziness or fainting. A serious skin condition known as Acute Generalized Exanthematous Pustulosis (AGEP) is also documented in official sources.

Q: Is Atarax an antidepressant?

A: No, official drug classification is as an antihistamine with documented anxiolytic and sedative properties. It is not classified as an antidepressant. In fact, official adverse reaction reports sometimes include depression.

Q: Does Atarax affect heart rhythm or cause palpitations?

A: Yes, official warnings state that hydroxyzine has been associated with QT interval prolongation (a change in the heart's electrical activity) and rare events of Torsade de Pointes. The drug is contraindicated in patients with known risk factors for these heart rhythm issues.

Q: How quickly should I expect to feel the calming effect of Atarax after taking it?

A: Pharmacokinetic data in official sources indicate that the medication is generally absorbed rapidly. The maximum concentration of the drug in the blood typically occurs within approximately two hours after administration.

Q: What should be avoided when taking Atarax besides alcohol?

A: Official guidance strictly contraindicates the use of hydroxyzine with other medications known to prolong the QT interval or drugs that inhibit the CYP3A4/5 enzyme. Caution is also advised when taking any other Central Nervous System (CNS) depressants.

Q: Can taking Atarax make you feel dizzy or lightheaded?

A: Yes, official product information lists both dizziness and lightheadedness as possible side effects in the documented list of adverse reactions.

Q: Is Atarax approved for use in children?

A: Official labeling includes dosage information and indications for use in children, typically for the management of itching and as an adjunctive therapy for anxiety and tension in specific age groups.

Q: Does Atarax interact with common cold or flu medicines?

A: Many common cold and flu medicines contain components that are Central Nervous System (CNS) depressants. Official documents warn that hydroxyzine can potentiate (increase the effect of) other CNS depressants, thereby increasing the risk of sedation.

Q: Can Atarax cause vivid dreams or nightmares?

A: While vivid dreams are not explicitly listed, official labeling includes rare adverse psychiatric events in the post-marketing experience section, such as hallucinations and confusion.

Q: Is there a risk of developing a tolerance to Atarax over time?

A: Regulatory documents suggest that tolerance to the sedative effect of hydroxyzine may develop over time. This is one reason why general guidance recommends the medication be used for the shortest possible duration.

Q: What official warnings are there about Atarax and other sedating drugs?

A: Official warnings emphasize that the potentiating action of hydroxyzine must be considered when used with other Central Nervous System (CNS) depressants. This includes many non-narcotic analgesics, hypnotics, sedatives, and alcohol.

Q: Does Atarax make other medications I take stronger?

A: Official documents state that the drug may potentiate (increase or enhance the effect of) certain other medications. Specifically, this warning applies to drugs classified as Central Nervous System (CNS) depressants.

Q: Are there any specific foods to avoid when taking Atarax?

A: Official directions generally state that the medicine can be taken with or without food. The primary restriction on consumption involves alcohol, which is known to potentiate the drug's sedative effects.

Q: What is the difference between Atarax and Vistaril (hydroxyzine)?

A: Atarax is a brand name for the active ingredient hydroxyzine hydrochloride, while Vistaril is a brand name for hydroxyzine pamoate. Both formulations contain the same active antihistamine ingredient, hydroxyzine, and are described in official regulatory documents.

Q: Is Atarax prescribed for sleep problems (insomnia)?

A: While the drug is not officially indicated for chronic insomnia, official labeling includes its approved use as a sedative before and after general anesthesia. Its general Central Nervous System depressant properties contribute to this effect.

Q: Can Atarax cause dry mouth and what can be done about it?

A: Dry mouth (xerostomia) is explicitly listed as a common anticholinergic side effect in official adverse reaction reports. This side effect is a known result of the drug's mechanism.

Q: What evidence is there supporting the use of Atarax for itching?

A: Official indications list its use for pruritus (itching) due to various allergic conditions, supported by clinical experience and studies. Its action as an H1 antihistamine is key to this approved use.

Q: What kind of mental health conditions is Atarax primarily intended to address?

A: Official labeling specifically lists the management of anxiety and tension associated with psychoneurosis as a primary indication for the medication.

Q: What are the contraindications for Atarax (who should definitely not use it)?

A: Official contraindications include individuals with known hypersensitivity to the drug or its metabolites, those with a known prolonged QT interval, and those who are concurrently using certain medications that also prolong the QT interval or inhibit the CYP3A4/5 enzyme.

Q: Is it normal to feel a little 'foggy' the morning after taking Atarax?

A: Feelings described as 'foggy' align with documented Central Nervous System side effects such as drowsiness. Drowsiness is the most common adverse reaction, and confusion is also documented in official sources, particularly in older adults.

Q: Can Atarax cause an allergic reaction, and what are the symptoms?

A: Yes, hypersensitivity (allergic reaction) to the drug is a contraindication. Symptoms described in official documents include rash, urticaria, pruritus, and rare, serious skin reactions like Acute Generalized Exanthematous Pustulosis (AGEP).

Q: How is Atarax different from benzodiazepines like Xanax or Valium?

A: Atarax is classified as an antihistamine with anxiolytic properties, while benzodiazepines are controlled substances that act through a different mechanism (binding to GABAA receptors). Official guidance cautions that Atarax’s effects can be increased if taken with benzodiazepines.

Q: How long does Atarax stay in your system?

A: Pharmacokinetic data in official sources estimate that the average elimination half-life of the drug in adults is approximately 20 hours. This represents the time it takes for half of the drug to be eliminated from the body.

Q: Do regulatory bodies classify Atarax as an anxiolytic?

A: Official labeling describes the drug as a histamine H1-receptor antagonist that exhibits documented anxiolytic (anxiety-reducing) and sedative properties.

Q: Can Atarax cause constipation, and how common is it?

A: Constipation is listed as a possible side effect in the official adverse reaction reports. This is attributed to the drug’s mild antimuscarinic (or anticholinergic) properties.

Q: What does official guidance say about using Atarax during pregnancy?

A: Official guidance notes that clinical data in human beings are inadequate to establish safety in early pregnancy, and some authorities contraindicate its use during this period. Reports of adverse effects in neonates exposed during late pregnancy have been documented.

Q: Is there a recommended maximum duration for using Atarax?

A: Official documents specify that the effectiveness for long-term use (more than four months for anxiety) has not been systematically assessed. General guidance recommends use for the shortest possible duration and lowest effective dose.

Q: Does Atarax interact with blood pressure medications?

A: Official guidance contains warnings regarding use in patients with cardiovascular conditions. The label also warns against combining it with drugs that can cause QT interval prolongation or bradycardia (slow heart rate), which includes certain types of blood pressure medications.

Q: Is it safe to drink coffee or caffeine while taking Atarax?

A: Official documents do not typically address caffeine or coffee specifically. However, a warning exists that the drug can potentiate the effects of Central Nervous System (CNS) depressants, and common side effects include drowsiness and sedation.

Q: What are the main active ingredients in Atarax?

A: The main active ingredient is hydroxyzine hydrochloride (or hydroxyzine pamoate for the Vistaril form), which is classified as a histamine H1-receptor antagonist.

Q: Does Atarax affect mood in a way other than reducing anxiety?

A: Official adverse reaction reports include rare documented psychiatric effects such as hallucinations and, in some cases, exacerbation of mental depression.

Q: Are there different strengths of Atarax tablets available?

A: Official product labeling confirms that the drug is available in various strengths and forms. These commonly include tablets of 10 mg, 25 mg, 50 mg, and 100 mg.

Q: Is Atarax a drug with a potential for abuse?

A: Regulatory bodies have classified the drug as not a controlled substance. It is generally considered to have a low potential for abuse or addiction compared to scheduled Central Nervous System depressants.

Advertisements

How should Atarax (PSYCHOANALEPTICS) be stored and disposed of?

Official Storage and Disposal Instructions

Hydroxyzine (Atarax) must be stored at Controlled Room Temperature, defined as 20 to 25 C (68 to 77 F), with excursions permitted to 30 C. All formulations must be kept out of the reach of children, and oral forms require a child-resistant closure on the container.

Storage Requirement Specific Constraint
Temperature Range 20 to 25 C (68 to 77 F)
Environmental Protection Protect from light (injection) and moisture (capsules)
Packaging Dispense in a tight, light-resistant container

Unused or expired hydroxyzine should be disposed of by following specific instructions, preferably by utilizing an authorized drug take-back program. If this is unavailable, the product should be mixed with an undesirable substance (such as dirt) and sealed for disposal in the household trash; the drug should not be flushed.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Atarax (PSYCHOANALEPTICS) found in:

A-Z Index: